Tuesday - June 9, 2026
Journals Medical Newsletter for Wednesday May 06, 2026 ( 8 items )  

Elkin honored in inaugural fellows of ACTS cohort
BUFFALO, New York, May 4 -- The University at Buffalo (State University of New York) posted the following news release: * * * Elkin honored in inaugural fellows of ACTS cohort * By Dirk Hoffman BUFFALO, N.Y. - The Association for Clinical and Translational Science (ACTS) has honored Peter L. Elkin, MD, UB Distinguished Professor and chair of biomedical informatics at the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo, with inclusion in the inaugural cohort o  more

HKU Engineering Researchers Create Durable, Skin-Friendly Soft Materials for Next-Gen Wearable and Biomedical Devices
HONG KONG, May 5 -- The University of Hong Kong issued the following news release: * * * HKU Engineering Researchers Create Durable, Skin-Friendly Soft Materials for Next-Gen Wearable and Biomedical Devices * The development of soft materials that can reliably function on the human body is important for the future of bioelectronics and wearable medical devices. These materials need to comfortably conform to the skin while being durable enough for everyday use. However, many existing soft mat  more

How can the same genetic mutation lead to different clinical outcomes?
UNIVERSITY PARK, Pennsylvania, May 5 -- Pennsylvania State University posted the following news: * * * How can the same genetic mutation lead to different clinical outcomes? * UNIVERSITY PARK, Pa. -Individuals that share the same deletion of a portion of chromosome 16 are at risk of developing neurodevelopmental disorders, but some experience severe intellectual disability or developmental delay, while others may only exhibit milder psychiatric features like depression or anxiety. How can th  more

Johnson & Johnson Study Shows Tremfya is the First and Only IL-23 Inhibitor to Demonstrate Efficacy in Perianal Fistulizing Crohn's Disease
RARITAN, New Jersey, May 6 -- Johnson and Johnson Innovative Medicine issued the following news release on May 5, 2026: * * * Johnson & Johnson study shows TREMFYA(R) (guselkumab) is the first and only IL-23 inhibitor to demonstrate efficacy in perianal fistulizing Crohn's disease TREMFYA(R) demonstrated significantly higher rates of combined fistula remission - complete external closure of draining fistulas and absence of fluid collection on MRI - compared to placebo at Week 24 First study   more

Oracle Supports Africa Clinical Research Network (ACRN) to Advance a New Era of Clinical Research, Launches First Trial
REDWOOD SHORES, California, May 5 [Category: BizComputer Technology] -- Oracle, a developer of hardware and software products, posted the following news release: * * * Oracle Supports Africa Clinical Research Network (ACRN) to Advance a New Era of Clinical Research, Launches First Trial * The Africa Clinical Research Network (ACRN) has launched its first clinical trial with Oracle in Africa, which commenced in February 2026. The PROgnostic Testing to Enhance Clinical Triage of Pre-eclampsia   more

Outrageous and Appalling: Censorship of FDA and CDC Vaccine Studies
WASHINGTON, May 5 [Category: Political] -- Public Citizen issued the following news release: * * * Outrageous and Appalling: Censorship of FDA and CDC Vaccine Studies Officials at the U.S. Food and Drug Administration (FDA) blocked publication of several studies supporting the safety of widely used vaccines against COVID-19 and shingles. Two COVID-19 studies had already been accepted for publication in medical journals, and abstracts of the shingles studies were to be submitted to a drug safe  more

Post-Acute & Long-Term Care Medical Association Issues Commentary: Refocusing Response to Family Conflict
COLUMBIA, Maryland, May 5 -- Post-Acute and Long-Term Care Medical Association issued the following commentary on May 4, 2026, by Joanne Kaldy, freelance writer in New Orleans, Louisiana: * * * Refocusing Response to Family Conflict Family dynamics are complicated; so, it is not uncommon for post-acute and long-term care (PALTC) facility residents and their families to have different opinions or perspectives. When these arise, the differences and conflicts can have a positive or negative impa  more

Study Links Childhood Adversity, Heart Disease Risk in Adulthood
STORRS, Connecticut, May 5 -- The University of Connecticut posted the following news: * * * Study Links Childhood Adversity, Heart Disease Risk in Adulthood * Lifestyle, environment, and genetics can shape heart disease risk, but a new study from UConn researchers explores how negative childhood incidents impact heart health in adulthood. Ryan Talbert and Raja Staggers-Hakim, both assistant professors of sociology, and Jolaade Kalinowski, an assistant professor of human development and fa  more